Swiss holding company that owns private hospitals and clinics (Swiss Medical Network) plus hotel and hospitality assets.
Swiss holding company that owns private hospitals and clinics (Swiss Medical Network) plus hotel and hospitality assets.
In one line: A diversified private-hospital and hospitality holding company.
Moat: narrow (brand, installed base, regulatory licence). Licensed private-hospital network with established referral base in Switzerland's private healthcare market.
Headquarters: Fribourg, Switzerland · Founded: 1994 · Employees: 4,870
Size Aevis Victoria (AEVS.SW) is a Switzerland Health Care company (Hospital/Nursing Management) with a market value of $1.43B, the 109th largest of 155 Switzerland companies the cockpit tracks. Shares closed at CHF 14.15 on 18 Nov 2026.
Performance Over six months the shares gained 8.0%, against -6.9% for the median peer and +9.3% for the Switzerland market (cap-weighted) — 7th highest of 20 in its peer set.
Growth Revenue grew 14.9% over the last twelve months (peer median +8.7%); the operating margin is -5.9% (peer median 10.0%).
Valuation It trades at 106.8× forward earnings against a peer median of 28.9× (3rd most expensive of 17).
Price implies For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +10%, so the hurdle is +16 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 8.7 points below its cost of capital (5.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CHF 1.20B | CHF 1.13B | CHF 966M | CHF 914M | CHF 1.03B |
| Revenue growth | — | +17% | +6% | -11% | — |
| Gross profit | CHF 196M | CHF 193M | CHF 174M | CHF 170M | CHF 185M |
| EBITDA | CHF 9.10M | CHF 24.9M | CHF 22.0M | CHF 24.3M | CHF 39.2M |
| Net income | -CHF 18.9M | -CHF 20.1M | -CHF 2.87M | -CHF 39.3M | CHF 58.8M |
| Free cash flow | CHF 22.5M | CHF 36.0M | CHF 12.8M | -CHF 43.8M | CHF 58.8M |
| Capital expenditure | CHF 93.6M | CHF 67.7M | CHF 65.3M | CHF 109M | CHF 74.0M |
| Total debt | n/a | CHF 950M | CHF 1.07B | CHF 1.00B | CHF 970M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | AEVS.SW | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.4% | +1.6% | 5th lowest of 20 |
| 6-month return | +8.0% | -6.9% | 7th highest of 20 |
| Distance from 52-week high | -11.6% | -22.2% | 6th highest of 21 |
| Revenue growth (TTM) | +14.9% | +8.7% | 9th highest of 21 |
| Operating margin | -5.9% | 10.0% | 2nd lowest of 21 |
| Forward P/E | 106.8× | 28.9× | 3rd most expensive of 17 |
| Growth the price implies (Req g, 7 yrs) | 26.5% | 11.8% | 2nd most demanding of 15 |
| Growth delivered (Del g) | +10.2% | +9.5% | 7th highest of 15 |
| Hurdle (Req g minus delivered) | +16.3 pp | +1.2 pp | 2nd most demanding of 15 |
| ROIC minus cost of capital | -8.7 pp | -2.2 pp | 2nd lowest of 21 |
| Net debt / EBITDA | 103.2× | 2.6× | most indebted of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 27.1× | -2.7% | +6.1% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 14.6× | 14.2% | +6.9% |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 49.4× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% | +8.7% |
| Brookdale Senior Living BKD | United States | $2.06B | -36% | -8% | 6% | 482.6× | 19.3% | -1.4% |
| Ramsay Generale de Sante GDS.PA | France | $969M | -25% | +3% | 4% | n/a | 6.1% | +6.0% |
| Paras Healthcare PARASHLTH.NS | India | $962M | n/a | +24% | 11% | n/a | n/a | n/a |
| HealthCare Global Enterprises HCG.NS | India | $955M | -7% | +13% | 8% | 88.8× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $923M | -18% | +6% | 10% | n/a | 21.2% | +11.8% |